美国食品和药物管理局不良事件报告系统中与 GLP-1 受体激动剂相关的甲状腺增生和肿瘤不良事件（预印本）

{"title":"美国食品和药物管理局不良事件报告系统中与 GLP-1 受体激动剂相关的甲状腺增生和肿瘤不良事件（预印本）","authors":"T. Makunts, H. Joulfayan, R. Abagyan","doi":"10.2196/55976","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":508690,"journal":{"name":"JMIRx Med","volume":"6 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Thyroid hyperplasia and neoplasm adverse events associated with GLP-1 receptor agonists in FDA Adverse Event Reporting System (Preprint)\",\"authors\":\"T. Makunts, H. Joulfayan, R. Abagyan\",\"doi\":\"10.2196/55976\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":508690,\"journal\":{\"name\":\"JMIRx Med\",\"volume\":\"6 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JMIRx Med\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2196/55976\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JMIRx Med","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2196/55976","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}